Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Utilizing travel rewards can help lessen your credit card payments. Discover strategies to turn your travel rewards into savings.
20,146 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Want anchors in a stormy market? Meet three dividend stocks never sell. These blue-chip picks blend reliable cash flo...
Ripple's XRP Ledger is steering into autonomous, machine-to-machine payments backed by a $5 million seed and a major ...
U.S. businesses are starting to receive their IEEPA tariff refunds, delivering relief to cash flows and inventory pla...
The MBA reports a 1.0% weekly rise in mortgage applications, driven by refinancing activity as rates paused near 6.6%...
If you crave a reliable, growing cash flow from your investments, energy stocks can be a smart piece of the puzzle. T...
A new forecast from microsoft leading copilot predicts XRP could reach as high as $15 by end-2026 if regulatory clari...
Volatility in markets remains elevated, and two monthly dividend ETFs built for lower volatility are drawing attentio...
A marquee collaboration turned cautionary tale. Explore how a failed merch deal unfolded, what it cost, and how to sh...
Rumble faces a pivotal quarter as it navigates growth, monetization, and cost control. This article breaks down what ...
Open Standard announces Open USD, a new stablecoin backed by 140 plus firms including Stripe and Visa, set to launch ...
Analysts are warming to a pair of fintech names as valuations cool and growth metrics improve. This report explains w...